Abstract
Specific targeting of liposome-formulated cytotoxic drugs or antigens to receptors expressed selectively on target cells represents an effective strategy for increasing the pharmacological efficacy of the delivered molecules. We have developed a feasible technique to selectively attach antibodies and fragments thereof, but also small-mol-wt ligands such as peptides, carbohydrates, or any molecules that recognize and bind target antigens or receptors to the surface of small unilamellar liposomes. Our concept is based on the site-specific functionalization of the ligands to be attached to the liposomes by thiol groups. These thiol groups can easily be introduced to antibodies or peptides by addition of cysteines, preferably at sites that do not interfere with the receptor binding domains. Optimally, the site-specific modification is introduced at the C-terminal end of the ligand, separated by an inert spacer sequence located between the thiols and the specific part of the ligand. The thiol-reactive molecules on the liposome surface are maleimides that are linked to phospholipids composing the liposome bilayer membrane. We illustrate the coupling method of a functionalized single-chain antibody fragment with binding specificity to ED-B fibronectin, an isoform of fibronectin exclusively expressed in tumor tissues, to long circulating small unilamellar poly(ethylene glycol) liposomes.
Key Words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Sapra, P. and Allen, T. M. (2003) Ligand-targeted liposomal anticancer drugs. Progr. Lipid Res. 42, 439–462.
Allen, T. M. (2002) Ligand-targeted therpeutics in anticancertherapy. Nat. Rev. Cancer 2, 750–762.
Marty, C., Ballmer-Hofer, K., Neri, D., Klemenz, R., Schott, H., and Schwendener, R. A. (2002) Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes. Br. J. Cancer 87, 106–112.
Ludewig, B., Barchiesi, F., Pericin, M., Zinkernagel, R. M., Hengartner, H., and Schwendener, R. A. (2000) In vivo antigen loading and activation of dendritic cells via a liposo-mal peptide vaccine mediated protective antiviral and antitumor immunity. Vaccine 19, 23–32.
Huang, C. and Mason, J. T. (1978) Geometric packing constraints in egg phosphatidylcho-line vesicles. Proc. Natl. Acad. Sci. USA 75, 308–310.
Rubas, W., Supersaxo, A. Weder, H. G., et al. (1986) Treatment of murine L1210 leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes. Int J. Cancer 37, 149–154.
Mayer, L. D., Hope, M. J., and Cullis, P. R. (1986) Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta 858, 161–168.
Marty, C., Scheidegger, P., Ballmer-Hofer, K., Klemenz, R., and Schwendener, R. A. (2001) Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris. Protein Expr. Purif. 21, 156–164.
Ellsdale, T. and Bard, J. (1972) Collagen substrata for studies on cell behaviour. J. Cell. Biol. 54, 626–637.
Schwendener, R. A., Asanger, M., and Weder, H. G. (1981) The preparation of large bilayer liposomes: controlled removal of n-alkyl-glucoside detergents from lipid/deter-gent micelles. Biochem. Biophys. Res. Commun. 100, 1055–1062.
Schwendener, R. A. (1986) The preparation of large volumes of homogeneous, sterile liposomes containing various lipophilic cytostatic drugs by the use of a capillary dialyzer. Cancer Drug Delivery 3, 123–129.
Mayer, L. D., Hope, M. J., Cullis, P. R., and Janoff, A. S. (1985) Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim. Biophys. Acta 817, 193–196.
Eyer, P., Worek, F., Kiderlen, D., et al. (2003) Molar absorption coefficients for the reduced Ellman reagent: reassessment. Anal. Biochem. 312, 224–227.
Console, S., Marty, C., Garcia-Echeverria, C., Schwendener, R. A., and Ballmer-Hofer, K. (2003) Antennapedia and HIV TAT "e;protein transduction domains"e; promote endocy-tosis of high Mr cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278(37), 35,109–35,114.
Burmeister Getz, E., Xiao, M., Chakrabarty, T., Cooke, R., and Selvin, P. R. (1999) A comparison between the sulfhydryl reductants tris(2-carboxyethyl)phosphine and dithiothreitol for use in protein biochemistry. Anal. Biochem. 273, 73–80.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Marty, C., Schwendener, R.A. (2005). Cytotoxic Tumor Targeting With scFv Antibody-Modified Liposomes. In: Ludewig, B., Hoffmann, M.W. (eds) Adoptive Immunotherapy: Methods and Protocols. Methods in Molecular Medicine™, vol 109. Humana Press. https://doi.org/10.1385/1-59259-862-5:389
Download citation
DOI: https://doi.org/10.1385/1-59259-862-5:389
Publisher Name: Humana Press
Print ISBN: 978-1-58829-406-7
Online ISBN: 978-1-59259-862-5
eBook Packages: Springer Protocols